• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者择期行腹外疝修补术的最佳临床阈值建模。

Modeling Optimal Clinical Thresholds for Elective Abdominal Hernia Repair in Patients With Cirrhosis.

机构信息

Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.

出版信息

JAMA Netw Open. 2022 Sep 1;5(9):e2231601. doi: 10.1001/jamanetworkopen.2022.31601.

DOI:10.1001/jamanetworkopen.2022.31601
PMID:36098965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9471978/
Abstract

IMPORTANCE

Patients with cirrhosis have increased risk of postoperative mortality. Several models have been developed to estimate this risk; however, current risk estimation scores cannot compare surgical risk with the risk of not operating.

OBJECTIVE

To identify clinical optimal thresholds to favor operative or nonoperative management for a common cirrhosis surgical scenario, the symptomatic abdominal hernia.

DESIGN, SETTING, AND PARTICIPANTS: This was a Markov cohort decision analytical modeling study evaluating elective surgery vs nonoperative management for a symptomatic abdominal hernia in a patient with cirrhosis. Transition probabilities and utilities were derived from the literature and from data using an established cirrhosis cohort in the Veterans Health Administration. Participants included patients who were referred to a surgery clinic for a symptomatic abdominal hernia. Data were obtained from patients diagnosed with cirrhosis between January 1, 2008 and December 31, 2018. Data were analyzed from January 1 to May 1, 2022.

MAIN OUTCOMES AND MEASURES

Expected quality-adjusted life-years (QALYs) were estimated for each pathway and iterated over baseline model for end-stage liver disease-sodium (MELD-Na) scores ranging from 6 to 25. Markov models were cycled over a 5-year time horizon.

RESULTS

A total 2740 patients with cirrhosis (median [IQR] age, 62 [56-66] years; 2699 [98.5%] men) were referred to a surgery clinic for a symptomatic abdominal hernia; 1752 patients (63.9%) did not receive surgery. The median (IQR) follow-up was 42.1 (25.3-70.0) months. Using this cohort to estimate the mortality risk of operative and nonoperative pathways, an initial MELD-Na threshold of 21.3 points, below which surgery was associated with maximized QALYs was identified. Nonoperative management was associated with increased QALYs above this MELD-Na threshold. Although more patients experienced death with a surgical treatment decision across all initial MELD-Na values, this was counterbalanced by increased time spent in a resolved hernia state associated with increased utility. Model results were sensitive to the probability of hernia recurrence and hernia incarceration and utility decrement in the symptomatic hernia state.

CONCLUSIONS AND RELEVANCE

This decision analytical model study found that elective surgical treatment for a symptomatic abdominal hernia was favored even in the setting of relatively high MELD-Na scores. Patient symptoms, hernia-specific characteristics, and surgeon and center expertise may potentially impact the optimal strategy, emphasizing the importance of shared decision-making.

摘要

重要性

患有肝硬化的患者术后死亡率增加。已经开发了几种模型来估计这种风险;然而,目前的风险评估评分不能将手术风险与不手术的风险进行比较。

目的

确定临床最佳阈值,以有利于肝硬化常见手术情况,即症状性腹部疝的手术或非手术治疗。

设计、设置和参与者:这是一项马尔可夫队列决策分析模型研究,评估了对肝硬化患者症状性腹部疝进行择期手术与非手术治疗的情况。转移概率和效用来自文献和使用退伍军人健康管理局中已建立的肝硬化队列的数据。参与者包括因症状性腹部疝而被转介到手术诊所的患者。数据来自 2008 年 1 月 1 日至 2018 年 12 月 31 日期间被诊断为肝硬化的患者。数据于 2022 年 1 月 1 日至 5 月 1 日进行分析。

主要结果和测量

为每个路径估计了预期的质量调整生命年(QALY),并对终末期肝病钠(MELD-Na)评分从 6 到 25 的基线模型进行了迭代。马尔可夫模型在 5 年的时间范围内循环。

结果

共有 2740 名肝硬化患者(中位[IQR]年龄,62[56-66]岁;2699[98.5%]男性)因症状性腹部疝被转介至手术诊所;1752 名患者(63.9%)未接受手术。中位(IQR)随访时间为 42.1(25.3-70.0)个月。使用该队列估计手术和非手术途径的死亡率风险,确定了初始 MELD-Na 阈值为 21.3 分,低于该阈值,手术与最大化 QALY 相关。在这个 MELD-Na 阈值以上,非手术治疗与增加的 QALY 相关。尽管在所有初始 MELD-Na 值下,手术治疗决策都会导致更多患者死亡,但这被与增加的效用相关的疝状态的解决时间增加所抵消。模型结果对疝复发和疝嵌顿的概率以及症状性疝状态下的疝效用下降敏感。

结论和相关性

这项决策分析模型研究发现,即使在相对较高的 MELD-Na 评分下,对症状性腹部疝进行择期手术治疗也是有利的。患者症状、疝的具体特征以及外科医生和中心的专业知识可能会影响最佳策略,强调了共同决策的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c66/9471978/86335429bbe1/jamanetwopen-e2231601-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c66/9471978/67ee3c07db84/jamanetwopen-e2231601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c66/9471978/2c0af8a3d511/jamanetwopen-e2231601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c66/9471978/86335429bbe1/jamanetwopen-e2231601-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c66/9471978/67ee3c07db84/jamanetwopen-e2231601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c66/9471978/2c0af8a3d511/jamanetwopen-e2231601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c66/9471978/86335429bbe1/jamanetwopen-e2231601-g003.jpg

相似文献

1
Modeling Optimal Clinical Thresholds for Elective Abdominal Hernia Repair in Patients With Cirrhosis.肝硬化患者择期行腹外疝修补术的最佳临床阈值建模。
JAMA Netw Open. 2022 Sep 1;5(9):e2231601. doi: 10.1001/jamanetworkopen.2022.31601.
2
A prospective study on elective umbilical hernia repair in patients with liver cirrhosis and ascites.前瞻性研究肝硬化伴腹水患者择期行脐疝修补术。
Surgery. 2011 Sep;150(3):542-6. doi: 10.1016/j.surg.2011.02.026. Epub 2011 May 31.
3
Abdominal wall hernia in cirrhotic patients: emergency surgery results in higher morbidity and mortality.肝硬化患者的腹壁疝:急诊手术会导致更高的发病率和死亡率。
BMC Surg. 2015 May 21;15:65. doi: 10.1186/s12893-015-0052-y.
4
Model for End-Stage Liver Disease Sodium as a Predictor of Surgical Risk in Cirrhotic Patients With Ascites.终末期肝病模型钠作为腹水肝硬化患者手术风险的预测因子。
J Surg Res. 2020 Jun;250:45-52. doi: 10.1016/j.jss.2019.12.037. Epub 2020 Feb 1.
5
Incidence and Risk Factors of Postoperative Mortality and Morbidity After Elective Versus Emergent Abdominal Surgery in a National Sample of 8193 Patients With Cirrhosis.在一个 8193 例肝硬化患者的全国样本中,择期与紧急腹部手术后的术后死亡率和发病率的发生率和危险因素。
Ann Surg. 2021 Oct 1;274(4):e345-e354. doi: 10.1097/SLA.0000000000003674.
6
The abdominal wall hernia in cirrhotic patients: a historical challenge.肝硬化患者的腹壁疝:历史挑战。
World J Emerg Surg. 2018 Jul 28;13:35. doi: 10.1186/s13017-018-0196-z. eCollection 2018.
7
Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis.肝硬化患者术后死亡率的风险预测模型。
Hepatology. 2021 Jan;73(1):204-218. doi: 10.1002/hep.31558. Epub 2020 Dec 10.
8
Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals.多种安全网医院肝硬化患者肝移植转诊的相关因素。
JAMA Netw Open. 2023 Jun 1;6(6):e2317549. doi: 10.1001/jamanetworkopen.2023.17549.
9
Management of cirrhotic patients with blunt abdominal trauma: analysis of risk factor of postoperative death with the Model for End-Stage Liver Disease score.肝硬化合并钝性腹部创伤患者的管理:终末期肝病模型评分分析术后死亡的危险因素。
Injury. 2012 Sep;43(9):1457-61. doi: 10.1016/j.injury.2011.03.057. Epub 2011 Apr 20.
10
External Validation of the VOCAL-Penn Cirrhosis Surgical Risk Score in 2 Large, Independent Health Systems.在 2 个大型独立医疗系统中对 VOCAL-Penn 肝硬化手术风险评分进行外部验证。
Liver Transpl. 2021 Jul;27(7):961-970. doi: 10.1002/lt.26060.

引用本文的文献

1
Pre-Operative Assessment of Patients with Cirrhosis for Extrahepatic Surgery.肝硬化患者肝外手术的术前评估
Curr Hepatol Rep. 2025;24(1):25. doi: 10.1007/s11901-025-00697-4. Epub 2025 Jun 4.
2
Pilot Case Series of Robotic-Assisted Hernia Repair in Patients With Cirrhosis.肝硬化患者机器人辅助疝修补术的初步病例系列
J Abdom Wall Surg. 2025 Apr 24;4:14226. doi: 10.3389/jaws.2025.14226. eCollection 2025.
3
Perioperative Risk in Patients With Cirrhosis.肝硬化患者的围手术期风险

本文引用的文献

1
Risk factors for adverse outcomes in emergency versus nonemergency open umbilical hernia repair and opportunities for elective repair in a national cohort of patients with cirrhosis.在全国肝硬化患者队列中,与非紧急开放性脐疝修补术相比,急诊开放性脐疝修补术不良结局的风险因素,以及择期修补的机会。
Surgery. 2022 Jul;172(1):184-192. doi: 10.1016/j.surg.2021.12.004. Epub 2022 Jan 19.
2
Risk Prediction Models for Postoperative Decompensation and Infection in Patients With Cirrhosis: A Veterans Affairs Cohort Study.肝硬化患者术后失代偿和感染的风险预测模型:退伍军人事务队列研究。
Clin Gastroenterol Hepatol. 2022 May;20(5):e1121-e1134. doi: 10.1016/j.cgh.2021.06.050. Epub 2021 Jul 8.
3
Gastroenterol Hepatol (N Y). 2024 Aug;20(5):290-293.
4
Surgical risk stratification in patients with cirrhosis.肝硬化患者的手术风险分层。
Hepatol Int. 2024 Jun;18(3):876-891. doi: 10.1007/s12072-024-10644-y. Epub 2024 Mar 12.
Surgeons preference for lumbar disk surgery: a discrete choice experiment.
外科医生对腰椎间盘手术的偏好:一项离散选择实验。
Eur Spine J. 2022 Feb;31(2):380-388. doi: 10.1007/s00586-021-06838-9. Epub 2021 Apr 19.
4
External Validation of the VOCAL-Penn Cirrhosis Surgical Risk Score in 2 Large, Independent Health Systems.在 2 个大型独立医疗系统中对 VOCAL-Penn 肝硬化手术风险评分进行外部验证。
Liver Transpl. 2021 Jul;27(7):961-970. doi: 10.1002/lt.26060.
5
Assessment of health-related quality of life and health utilities in Australian patients with cirrhosis.澳大利亚肝硬化患者健康相关生活质量及健康效用评估。
JGH Open. 2020 Dec 10;5(1):133-142. doi: 10.1002/jgh3.12462. eCollection 2021 Jan.
6
Trends in surgical volume and in-hospital mortality among United States cirrhosis hospitalizations.美国肝硬化住院患者的手术量和住院死亡率趋势。
Ann Gastroenterol. 2021;34(1):85-92. doi: 10.20524/aog.2020.0554. Epub 2020 Nov 20.
7
Frailty Is a Risk Factor for Postoperative Mortality in Patients With Cirrhosis Undergoing Diverse Major Surgeries.衰弱是多种主要手术治疗的肝硬化患者术后死亡的危险因素。
Liver Transpl. 2021 May;27(5):699-710. doi: 10.1002/lt.25953. Epub 2021 Feb 15.
8
Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis.肝硬化患者术后死亡率的风险预测模型。
Hepatology. 2021 Jan;73(1):204-218. doi: 10.1002/hep.31558. Epub 2020 Dec 10.
9
Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.综述文章:肝硬化患者的营养不良/肌肉减少症和衰弱。
Aliment Pharmacol Ther. 2020 Jan;51(1):64-77. doi: 10.1111/apt.15571. Epub 2019 Nov 8.
10
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.美国胃肠道、肝脏和胰腺疾病的负担和成本:2018 年更新。
Gastroenterology. 2019 Jan;156(1):254-272.e11. doi: 10.1053/j.gastro.2018.08.063. Epub 2018 Oct 10.